期刊文献+

联合血液学指标和超声建立甲状腺结节术前良恶性鉴别模型 被引量:3

Model Analysis of Pre-surgical Identification Between Benign and Malignant Thyroid Nodules by Blood Tests and Ultrasound
下载PDF
导出
摘要 目的结合大量临床诊断病例的验证分析,寻找术前甲状腺结节相关指标,建立甲状腺结节良恶性鉴别早期辅助诊断模型。方法研究解放军总医院收治甲状腺结节住院患者并及时收集其术前血液样本用于生化、甲功、血常规等相关指标测定。回顾性验证分析术前病人一般资料、临床血液学数据、超声结果与术后病理诊断的相关性。结果入选Logistic回归方程指标包括年龄(Age)、血清促甲状腺激素(TSH)、血清高密度脂蛋白(HDL)、中性粒细胞计数(N)、超声结果(Ult)5项,建模方程为Logit(P)=1.673-0.069X1+0.301X3-1.499X8+5.335X10+21.182X12,模型组联合ROC曲线下面积为0.882;验证组为0.812。结论通过模型分析初步建立甲状腺结节术前良恶性鉴别的血液学指标应用基础,联合超声为手术选择提供客观依据。 Objective To establish an auxiliary diagnosis model for differentiate diagnosis of benign and malignant thyroid nodules with a great quantity of clinical case validation. Methods The serum samples of inpatients with thyroid nodules before surgery were collected for biochemistry, thyroid hormones and blood cells testing and case history were used for retrospective analysis to determine the correlation between clinical blood, ultrasound and clinicopathologic analysis results. Results Index of Age, TSH, HDL, N and Ult were selected in Logistic regression equation establishment. The ROC area under curve of model team was 0. 882, and the ROC area under curve of validation team was 0. 812. Conclusion The model established in this study has been preliminary applied the blood tests for differentiate diagnosis of benign and malignant thyroid nodules before surgery. It could provide objective guidance for surgery combined with ultrasonic examination.
出处 《标记免疫分析与临床》 CAS 2015年第9期846-849,共4页 Labeled Immunoassays and Clinical Medicine
基金 863计划"心脑血管慢性损伤及急救指标等体外诊断试剂的研制"(2011AA02A111)
关键词 甲状腺结节 良性 恶性 术前鉴别 辅助诊断 模型 Thyroid nodule Benign Malignant Pre- surgical identification Auxiliary diagnosis Model
  • 相关文献

参考文献17

  • 1Baskin H J. Ultrasound-guided fine-needle aspiration biopsy of thyroid nodules and multinodular goiters. Endocr Pract,2004, 10 (3) :242-245.
  • 2甲状腺结节和分化型甲状腺癌诊治指南[J].中华内分泌代谢杂志,2012,28(10):779-797. 被引量:684
  • 3Langer P, Tajtakova M, Kocan A, et al. From naturally occurring goitrogens to the effects of anthropogenie endocrine disruptors on the thyroid in slovakia. Bratisl Lek Listy, 2003,104 (3) : 101 - 107.
  • 4Cooper D S, Doherty G M, Haugen B R, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 2006,16 ( 2 ) : 109-142.
  • 5Wienke J R, Chong W K, Fielding J R, et al. Sonographic features of benign thyroid nodules: interobserver reliability and overlap with malignancy. J Ultrasound Med ,2003,22 (10) : 1027-1031.
  • 6杨春梅,刘彦蜂.甲状腺腺瘤超声诊断及误诊分析[J].医学研究杂志,2006,35(12):92-93. 被引量:6
  • 7Pacini F, Schlumberger M, Dralle H, et al. [ European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium ]. Vestn Khir Im I I Grek,2008,167 ( 1 ) : 52-56.
  • 8American Thyroid Association (ATA) Guidelines Taskforee on Thyroid Nodules and Differentiated Thyroid Cancer, CooPer D S, Doherty G M, et al. Revised American Thyroid Association management guidelines for Patients with thyroid nodules and differentiated thyroid cancer. Thyroid ,2009,19 ( 11 ) : 1167-1214.
  • 9Oertel Y C, Miyahara-FeliPe L, Mendoza M G, et al. Value of repeated fine needle aspirations of the thyroid : an analysis of over ten thousand FNAs. Thyroid ,2007,17 ( 11 ) : 1061 - 1066.
  • 10Gallo M, Pesenti M, Valcavi R. Ultrasound thyroid nodule measurements :The " Gold standard" and its limitations in clinical decision making. Endocr Pract ,2003,9 ( 3 ) : 194-199.

二级参考文献38

  • 1刘洪枫,唐伟松,杨志英.甲状腺钙化性病灶与甲状腺癌[J].中国医学科学院学报,2003,25(5):626-629. 被引量:147
  • 2ZHURui-sen YUYong-li LUHan-kui LUOQuan-yong CHENLi-bo.Clinical study of 312 cases with matastatic differentiated thyroid cancer treated with large doses of ^(131)I[J].Chinese Medical Journal,2005(5):425-428. 被引量:10
  • 3牛丽娟,郝玉芝,周纯武.超声诊断甲状腺占位性病变的价值[J].中华耳鼻咽喉头颈外科杂志,2006,41(6):415-418. 被引量:117
  • 4中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5227
  • 5[12]Wunderbaldinger P,Harisinghani MG,Hahn PF,et al. Cystic lymph node metastases in papillary thyroid carcinoma[J]. American Journal of Roentgenography,2002,178(2):693-697.
  • 6[1]James C,Starks M,MacGillivray DC,et al. The use of imaging studies in the diagnosis and management of thyroid cancer and hyperparathyroidism[J]. Surg Oncol Clin N Am,1999,8(1):145-169.
  • 7[2]Galloway RJ,Smallridge RC. Imaging in thyroid cancer[J]. Endocrinology and Metabolism Clinics of North America,1996,25(1):93-113.
  • 8[3]Rago T,Vitti P,Chovato L,et al. Role of conventional ultrasonography and color flow Doppler sonography in predicting malignancy in "cold" thyroid nodules[J]. European Journal of Endocrinology,1998,138(1): 41-46.
  • 9[4]Koike E,Noguchi S,Yamashita H,et al. Ultrasonographic characteristics of thyroid nodules[J]. Arch Surg,2001,136(3):334-337.
  • 10[5]Kakkos SK,Scopa CD,Chalmoukis AK,et al. Relative risk of cancer in sonographically detected thyroid nodules with calcifications[J]. Journal of Clinical Ultrsound,2000,28(7): 347-352.

共引文献776

同被引文献69

引证文献3

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部